Optimise Platelet Production

Switching from single to double dose buffy coat platelet prodcution by pooling 7 to 8 optimised buffy coats, may lower the number of buffy coats required to obtain 2 therapeutic doses. The usage of platelet pooling sets, platelet additive solution (PAS) and INTERCEPT^TM processing sets can be reduced by 50%, and the number of sterile docks required can be reduced by up to 30%. 

On top of these savings, the double dose buffy coat platelet production process can add logistical and economic advantages. Treating 2 therapeutic doses at once reduces the number of illuminations by 50%, equally saving on hands-on time. This, in turn, can translate into economic value. 

Learn how double dose buffy coat platelet prodcution supported the affordability of the INTERCEPT^TM Blood System for platelets at the Karolinska University Hospital.

Challenge, solution and results: making the implementation of the INTERCEPT^TM Blood System for platelets affordable at the Karolinska University Hospital.